CDC, FDA end pause on use of Johnson & Johnson Covid-19 vaccine, following review
Lifting of pause comes after 11-day safety review
Federal health officials from the Centers for Disease Control and Prevention and the Food and Drug Administration on Friday evening ended a pause on the use of the Johnson & Johnson COVID-19 vaccine, following an 11-day review by a panel of experts.
"We have concluded that the known and potential benefits of the Janssen COVID-19 Vaccine outweigh its known and potential risks in individuals 18 years of age and older," acting FDA Commissioner Janet Woodcock said in a statement. "We are confident that this vaccine continues to meet our standards for safety, effectiveness and quality."
Officials recently paused the use of vaccine following a small percentage of patients having gotten blood clots.
News, Not Noise
- Georgia investigator's notes reveal 'massive' election integrity problems in Atlanta
- Over 7,000 affidavits delivered to Michigan lawmakers claim election fraud
- Georgia audit documents expose significant election failures in state's largest county
- GOP lawmakers to Biden: 'We write to you today to express concern with your current cognitive state'
- Pelosi says GOP wants people 'in cars, on the road, using gas,' Dems want more mass transit